Asset Comparison and Correlation
|NYSE vs Biotest AG|
Given investment horizon of 30 days, NYSE is expected to generate 0.69 times more return on investment than Biotest. However, NYSE is 1.45 times less risky than Biotest. It trades about -0.15 of its potential returns per unit of risk. Biotest AG is currently generating about -0.27 per unit of risk. If you would invest 959,827 in NYSE on May 19, 2013 and sell it today you would lose (26,038) from holding NYSE or give up 2.71% of portfolio value over 30 days.
Match-ups for NYSE
Over the last 30 days Biotest AG has generated negative risk-adjusted returns adding no value to investors with long positions.
Match-ups for Biotest